Report Highlights
The global market for elder care services and assistive devices is expected to grow from $868.2 billion in 2024 and is projected to reach $1.1 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 5.8% during the forecast period of 2024 to 2029.
Report Includes
- 26 data tables and 26 additional tables
- An analysis of the global markets for elder care services and assistive medical devices
- Analyses of the global market trends, with market revenue data for 2022, estimates for 2023, forecasts for 2024, and projected CAGRs through 2029
- Estimate of the current market size and revenue growth prospects, along with a market share analysis by device type, service type, end user, and region
- Facts and figures pertaining to the market drivers, opportunities and challenges, emerging technologies, regulations and the impact of various macroeconomic factors
- Overview of sustainability trends and ESG developments in the industry, with a focus on consumer attitudes, companies’ ESG score rankings and their ESG practices
- An analysis of recent patents
- A look at the competitive landscape, including companies’ market shares, M&A activity and venture funding
- Profiles of the leading companies, including Brookdale Senior Living Inc., Sunrise Medical, Invacare Corp., Lifeline (a Philips company), and Atria Senior Living Inc.
Report Scope
This report explains critical trends in the elder care services and assistive devices market. The market analysis covers factors that serve as either motivating or inhibiting forces, offering valuable insights to stakeholders and potential new entrants. This study looks at research and development (R&D) spending, increasing competition and new technologies that are giving direction to the market. These advancements, new product launches and government programs will influence future market growth. The report also addresses company mergers, acquisition strategies and collaborations. Furthermore, it examines the strengths and weaknesses associated with each strategy type, considering emerging technologies, increased competition and evolving customer preferences. The market analysis focuses on elder care services and assistive devices.
Report Synopsis
Report Metrics | Details | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Base year considered | 2023 | ||||||||||
Forecast period considered | 2024-2029 | ||||||||||
Base year market size | $833.3 billion | ||||||||||
Market size forecast | $1.1 trillion | ||||||||||
Growth rate | CAGR of 5.8% for the forecast period of 2024-2029 | ||||||||||
Units considered | $ Billions | ||||||||||
Segments covered | Service, Type of Device, and Region | ||||||||||
Regions covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) | ||||||||||
Countries covered | China, India, Japan, South Korea, Australia, Singapore U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Russia, Latin America, and Africa | ||||||||||
Key Market Drivers |
|
||||||||||
Companies studied |
|
Frequently Asked Questions (FAQs)
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Consulting Editor’s Credentials
Dr. Marianna Tcherpakov has more than 10 years of experience as a bench scientist specializing in the areas of biochemistry, cell biology, assay development, antibody and drug manufacturing. She has authored several scientific publications in peer review journals. In the last 10 years, Marianna worked as a business development professional in CRO/CDMO industry. She is familiar with pharmaceutical and biotech landscape, trends and potential future developments in industry.
Report Highlights
The global market for elder care assistive devices should grow from $705.8 billion in 2020 to $914.9 billion by 2025, at compound annual growth rate (CAGR) of 5.3% for the period of 2020-2025.
Report Includes
- 12 data tables and 20 additional tables
- An overview of the global markets for elder care services and assistive devices
- Estimation of the market size and analyses of global market trends with data from 2019, estimates for 2020, and projections of compound annual growth rates (CAGRs) through 2025
- Highlights of quantitative and qualitative data of the eldercare products and services market by home healthcare, adult day services and institutional care, and medical/personal monitoring aids, daily living aids, mobility aids and access aids, and by region
- Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market trends, market size, market forecast, and technological advancements within the industry
- Impact analysis of COVID-19 on eldercare products and services market
- Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
- Company profiles of major players of the industry, including Atria Senior Living, Enlivant, Life Care Centers of America, Invacare Corp., and Sunrise Medical
Report Highlights
The U.S. eldercare market reached $381.6 billion in 2014 and nearly $417 billion in 2015. The market should reach $512.7 billion in 2020, demonstrating a compound annual growth rate (CAGR) of 4.2% from 2015 to 2020.
Report Includes
- An overview of the global markets for eldercare products and services.
- Analyses of market trends, with data from 2014, estimates for 2015, and projections of CAGRs through 2020.
- Segmentations of the market into healthcare products and services, housing services and needs, and assistive technologies.
- Breakdowns of the U.S. and worldwide markets by demographics.
- A focus on applications including:
- Heart disease/stroke.
- Cancer treatments.
- Kidney disease medications.
- Diabetes medications.
- Arthritis prescription medications.
- Osteoporosis medications.
- Pain medications.
- Neurological health medications (e.g., dementia, depression).
- Respiratory medications and products.
- Information covering the industry's structure.
- Profiles of major players in the industry.
Report Highlights
The U.S. eldercare market reached $286.7 billion in 2012. This market is expected to grow from $319.8 billion in 2013 to $436.6 billion by 2018, with a compound annual growth rate (CAGR) of 6.4% for the five-year period, 2013 to 2018.
Report Includes
- An in-depth analysis and forecast of the eldercare market.
- Analyses of market trends, with data from 2012, estimates for 2013, and projections of CAGRs for the period 2013 and 2018.
- Identification of the U.S. and worldwide markets by demographics.
- Discussion on international markets, as well as information on the industry's structure.
- A breakdown of the overall market into segments that include healthcare products and services, housing services and needs, and assistive technologies.
Report Highlights
- The U.S. eldercare market was worth $279.2 billion in 2008 and an estimated $316.9 billion in 2009. This should reach $447.4 billion in 2014, for a compound annual growth rate (CAGR) of 7.1%.
- The healthcare segment has the largest share of the market, worth $146.4 billion in 2008 and an estimated $172.2 billion in 2009. This should increase at a CAGR of 9.1% to reach $266.8 billion in 2014.
- The housing segment has the second-largest market share, generating $127.4 billion in 2008. This segment is expected to reach $138.7 billion in 2009 and $171.5 billion in 2014, for a CAGR of 4.3%.
Related Reports
Conventional and Alternative Pain Treatment Markets
The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
Wearable Medical Devices: Technologies and Global Markets
The global market for wearable medical devices was valued at $35.6 billion in 2023. This market is estimated to grow from $45.0 billion in 2024 to $151.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.5% from 2024 through 2029.
Home Medical Equipment: Technologies and Global Markets
The global market for home medical equipment (HME) is estimated to increase from $43.3 billion in 2022 to $64.8 billion by 2027, at a compound annual growth rate (CAGR) of 8.4% from 2022 through 2027.
Disabled and Elderly Assistive Technologies
The global market for assistive technology should grow from $44.1 billion in 2021 to $57.9 billion by 2026 with a compound annual growth rate (CAGR) of 5.6% for the period of 2021-2026.
Recent Reports
Conventional and Alternative Pain Treatment Markets
The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More